Recommended Alerts

Sign Up For Alerts

Antitrust and COVID-19

usinesses and institutions in many industries, including health care and life sciences, are considering ways to cooperate and collaborate in order to assist in addressing the public health crisis, as well as the economic crisis, caused by COVID-19 in the United States. Although these efforts – particularly among horizontal competitors – warrant assessing antitrust considerations, businesses can often engage in procompetitive collaboration with minimal or no antitrust risk. This Ropes & Gray alert sets forth some general principles, and provides an update on the recent Joint Statement by the Federal Trade Commission (“FTC”) and Antitrust Division of the Department of Justice (“DOJ”) dated March 24, 2020.

Read More

Supreme Court Holds General Authorization To County Hospital Authority Insufficient For Antitrust Immunity

Practices: Antitrust, Health Care, Appellate & Supreme Court

Printer-Friendly Version

Cookie Settings